Papers
3
Total Citations
26
H-Index
3
About
Aditya Kulkarni is a surgical oncologist whose work is reshaping the landscape of minimally invasive cancer surgery. His core research centers on the comparative effectiveness of robotic and video-assisted approaches for complex thoracic and abdominal malignancies, with a particular focus on esophageal and pancreatic cancers. In a landmark 2022 propensity score-matched analysis, Kulkarni demonstrated that robotic-assisted McKeown’s esophagectomy offers distinct advantages over video-assisted thoracoscopic surgery, a finding that has garnered 13 citations and informed surgical decision-making for esophageal cancer patients. His 2021 study on robotic versus open pancreatoduodenectomy for periampullary and pancreatic head malignancy, with 10 citations, provided crucial early evidence that robotic approaches can achieve comparable pathologic outcomes while potentially reducing recovery times. Beyond oncology, Kulkarni has contributed a comprehensive overview of bariatric and metabolic surgery, addressing the global obesity epidemic—India’s third-highest obesity rate—and highlighting the limitations of medical therapy alone. His work bridges the gap between technical innovation and patient outcomes, establishing him as a key voice in the evolution of robotic surgery for high-stakes oncologic and metabolic procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3